Taken together our data, with the observation that serum level of GM-CSF is significantly higher in colon adenocarcinoma patients [31], suggest that GM-CSF might represent a putative early marker in lung adenocarcinoma detection. This evidence concerns the gene CSF2 and lung adenocarcinoma.